Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science

Share Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

Sign up to save your podcasts

Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis

More shows like PeerVoice Internal Medicine Video

PeerVoice Oncology & Haematology Audio

PeerVoice Oncology & Haematology Video

PeerVoice Heart & Lung Audio

PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice Digestive Diseases Audio

PeerVoice Digestive Diseases Video

PeerVoice Immunology & Infectious Disease Video

PeerVoice Immunology & Infectious Disease Audio

PeerVoice Internal Medicine Audio